Endothelins and pulmonary hypertension, what directions for the near future? Eddahibi S., Adnot S. Eur Respir J 2001; 18: 1-4 | |
Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery Takahashi H., Soma S., Muramatsu M., Oka M., Ienaga H., Fukuchi Y. Eur Respir J 2001; 18: 5-14 | |
Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion Schutte H., Lockinger A., Seeger W., Grimminger F. Eur Respir J 2001; 18: 15-22 | |
A model of viral wheeze in nonasthmatic adults: symptoms and physiology Mckean M.C., Leech M., Lambert P.C., Hewitt C., Myint S., Silverman M. Eur Respir J 2001; 18: 23-32 | |
Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980-1997 Zar H.J., Stickells D., Toerien A., Wilson D., Klein M., Bateman E.D. Eur Respir J 2001; 18: 33-37 | |
Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma Juniper E.F., Norman G.R., Cox F.M., Roberts J.N. Eur Respir J 2001; 18: 38-44 | |
The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma Kon O.M., Sihra B.S., Loh L.C., Barkans J., Compton C.H., Barnes N.C., Larche M., Kay A.B. Eur Respir J 2001; 18: 45-52 | |
The voluntary drive to breathe is not decreased in hypercapnic patients with severe COPD Topeli A., Laghi F., Tobin M.J. Eur Respir J 2001; 18: 53-60 | |
Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients Van de Ven M.J.T., Colier W.N.J.M., Van der Sluijs M.C., Kersten B.T.P., Oeseburg B., Folgering H. Eur Respir J 2001; 18: 61-68 | |
Health-related quality of life in COPD: why both disease-specific and generic measures should be used Engstrom C.P., Persson L.O., Larsson S., Sullivan M. Eur Respir J 2001; 18: 69-76 | |
Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients Somfay A., Porszasz J., Lee S.M., Casaburi R. Eur Respir J 2001; 18: 77-84 | |
Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults Cerveri I., Accordini S., Verlato G., Corsico A., Zoia M.C., Casali L., Burney P., de Marco R. Eur Respir J 2001; 18: 85-92 | |
Partial liquid ventilation improves lung function in ventilation-induced lung injury Vazquez de Anda G.F., Lachmann R.A., Verbrugge S.J.C., Gommers D., Haitsma J.J., Lachmann B. Eur Respir J 2001; 18: 93-99 | |
Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury Maitre B., Boussat S., Jean D., Gouge M., Brochard L., Housset B., Adnot S., Delclaux C. Eur Respir J 2001; 18: 100-106 | |
The effects of pressurization rate on breathing pattern, work of breathing, gas exchange and patient comfort in pressure support ventilation Chiumello D., Pelosi P., Croci M., Bigatello L.M., Gattinoni L. Eur Respir J 2001; 18: 107-114 | |
Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids Olgart C., Frossard N. Eur Respir J 2001; 18: 115-121 | |
Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro Feldman C., Anderson R., Theron A.J., Steel H.C., van Rensburg C.E.J., Cole P.J., Wilson R. Eur Respir J 2001; 18: 122-129 | |
Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa Lindbom J., Ljungman A.G., Lindahl M., Tagesson C. Eur Respir J 2001; 18: 130-138 | |
Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression Silvestri M., Fregonese L., Sabatini F., Dasic G., Rossi G.A. Eur Respir J 2001; 18: 139-145 | |
Herpesvirus type 1-8 in BAL fluid from HIV-1-infected patients with suspected pneumonia and from healthy individuals Tarp B., Jensen-Fangel S., Dahl R., Obel N. Eur Respir J 2001; 18: 146-150 | |
Initial risk class and length of hospital stay in community-acquired pneumonia Menendez R., Ferrando D., Valles J.M., Martinez E., Perpina M. Eur Respir J 2001; 18: 151-156 | |
Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush Herer B., Fuhrman C., Demontrond D., Gazevic Z., Housset B., Chouaid C. Eur Respir J 2001; 18: 157-163 | |
Total energy expenditure in children with obstructive sleep apnoea syndrome Bland R.M., Bulgarelli S., Ventham J.C., Jackson D., Reilly J.J., Paton J.Y. Eur Respir J 2001; 18: 164-169 | |
Importance of sleep stage- and body position-dependence of sleep apnoea in determining benefits to auto-CPAP therapy Series F., Marc I. Eur Respir J 2001; 18: 170-175 | |
EGTA treatment of human airways in vitro unmasks M1/MUC5AC mucin in submucosal glands Roger P., Gascard J-P., Bara J., Dulmet E., Brink C. Eur Respir J 2001; 18: 176-183 | |
Pneumococcal vaccination: current and future issues Ortqvist A. Eur Respir J 2001; 18: 184-195 | |
Imaging of pneumonia: trends and algorithms Franquet T. Eur Respir J 2001; 18: 196-208 | |
Noninvasive mechanical ventilation in acute hypoxaemic respiratory failure Wysocki M., Antonelli M. Eur Respir J 2001; 18: 209-220 | |
Molecular physiology of oxygen-sensitive potassium channels Patel A.J., Honore E. Eur Respir J 2001; 18: 221-227 | |
European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers Boe J., Dennis J.H., O'Driscoll B.R., Bauer T.T., Carone M., Dautzenberg B., Diot P., Heslop K., Lannefors L. Eur Respir J 2001; 18: 228-242 | |
Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy Trisolini R., Lazzari Agli L., Tassinari D., Rondelli D., Cancellieri A., Patelli M., Falcone F., Poletti V. Eur Respir J 2001; 18: 243-245 | |
Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology Affrime M.B., Banfield C., Nolop K. Eur Respir J 2001; 18: 246 | |
Long-term treatment of pulmonary hypertension with aerosolized iloprost Saba T., Peacock A.J. Eur Respir J 2001; 18: 247 | |
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study Bergquist P., Crompton G.K. Eur Respir J 2001; 18: 248 | |